Changing Pattern of Human Listeriosis, England and Wales, 2001–2004 by Gillespie, Iain A. et al.
Microbiologic and epidemiologic data on 1,933 cases
of human listeriosis reported in England and Wales from
1990 to 2004 were reviewed. A substantial increase in inci-
dence occurred from 2001 to 2004. Ten clusters (60 cases),
likely to represent common-source outbreaks, were detect-
ed. However, these clusters did not account for the upsurge
in incidence, which occurred sporadically, predominantly in
patients >60 years of age with bacteremia and which was
independent of sex; regional, seasonal, ethnic, or socioe-
conomic differences; underlying conditions; or Listeria
monocytogenes subtype. The reasons for the increase are
not known, but since multiple L. monocytogenes strains
were responsible, this upsurge is unlikely to be due to a
common-source outbreak. In the absence of risk factors for
listeriosis in this emerging at-risk sector of the population,
dietary advice on avoiding high-risk foods should be provid-
ed routinely to the elderly and immunocompromised, not
just to pregnant women.
T
he bacterium Listeria monocytogenes and the disease
listeriosis were first recognized in laboratory animals
in 1924 (1). The disease also affects humans, most com-
monly the unborn, neonates, the immunocompromised,
and the elderly. Listeriosis manifests primarily as abortion,
septicemia, or central nervous system (CNS) infections,
with a high case-fatality rate in all patient groups.
Although most cases are foodborne, the epidemiology is
complex (2). The ubiquitous nature of the bacterium,
together with a varied incubation period (1 to >90 days),
means that identifying specific food vehicles can be prob-
lematic (3).
Human listeriosis was very rare in England and Wales
during the 1960s and 1970s but increased at the end of the
1980s. From 1987 to 1989, the incidence doubled, proba-
bly due to the consumption of contaminated pâté. After a
specific brand of pâté was withdrawn from retail sale and
warnings were issued to pregnant women and the immuno-
compromised to avoid eating this food, the incidence
declined (4). Throughout the 1990s, the average annual
total of cases was 110, but the numbers increased to 146,
136, 237, and 213 cases in 2001, 2002, 2003, and 2004
respectively (5). We describe preliminary surveillance data
on human listeriosis in England and Wales from 1990 to
2004 and speculate on reasons for the upsurge.
Materials and Methods
The Health Protection Agency Centre for Infections
(CFI) coordinates routine surveillance of human listeriosis
in England and Wales. Case ascertainment is by the volun-
tary reporting of laboratory-diagnosed cases from microbi-
ology laboratories through an electronic reporting system,
or by referral of cultures for identification and subtyping.
Epidemiologic and microbiologic data from both systems
are combined, checked for duplication, and stored in a
database. Additional demographic and clinical data are
sought from the responsible consultant medical microbiol-
ogists and local health protection teams with a standard
questionnaire.
L. monocytogenes isolates from patients with clinical
cases, food, and the environment referred to CFI are con-
firmed phenotypically (6) or by PCR (7). Isolates are char-
acterized by serotyping (8,9), phage typing until 2003 (10),
amplified fragment-length polymorphism (AFLP) analysis
since 2002 (11), and pulsed-field gel electrophoresis since
2003 on selected isolates (12).
For surveillance purposes, a patient with listeriosis was
defined as one with a compatible illness from whom L.
monocytogenes was isolated from a normally sterile site,
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categorized as pregnancy associated (all maternal-fetal
patients and neonatal patients; a mother-baby pair was
considered 1 case-patient) and nonpregnancy associated
(in a patient >1 month of age). Case-patients were catego-
rized further into those with CNS infections (L. monocyto-
genes isolated from CSF or brain tissue, clinical evidence
of infection of this organ, or both); bacteremia in the
absence of CNS infections (L. monocytogenes isolated
from blood but not from CNS and without clinical evi-
dence of CNS infection); and other conditions not includ-
ed in the previous 2 categories.
Data manipulation was undertaken in Microsoft Access
2003 (Microsoft Corporation, Redmond, WA, USA) and
MapInfo version 8.0 (MapInfo Corporation, Troy, NY,
USA). Ethnicity (categorized as ethnic or nonethnic) was
assigned by using patients’names (surname and first name
when available); patients’ ages were grouped into 10-year
bands. Indexes of deprivation for England (2004 [13]) and
Wales (2005 [14]), ranked and arranged into quintiles (1 =
most deprived and 5 = least deprived areas) and linked to
patients postal codes, were used as an approximate marker
for patients’ socioeconomic status. Patients’ postal codes
were also used as a marker for patients’residency. Internet
searches were used to determine if residential care homes
were situated in that postal code area or whether the hous-
ing was purely residential.
Data analysis was performed with Microsoft Excel,
EpiInfo version 6.04b (Centers for Disease Control and
Prevention, Atlanta, GA, USA) and Stata version 8.2
(StataCorp, College Station, TX, USA). Age-specific
denominator data from 1990 to 2004 were obtained from
the Office for National Statistics. Relative proportions and
changes in relative proportions with time were compared
by using the χ2 test and the χ2 test for trend, respectively.
Point estimates of relative risks (RRs) with accompanying




From January 1, 1990, to December 31, 2004, a total of
1,933 reported cases of human listeriosis in England and
Wales fulfilled the case definition. Of these 1,377 (71%)
were reported through the electronic surveillance system,
1,592 (82%) by isolate referral and 1,068 (55%) by both
means. During the study period, the proportion of isolates
referred did not change (χ2 for trend p = 0.94); the propor-
tion of electronic reports received increased slightly (χ2 for
trend p = 0.04). A total of 1,776 patients were admitted to
the hospital. For 1,187 patients for whom outcome data
were available, 522 (44%) died. From 1990 to 2000, the
mean annual incidence was 2.13 cases/million/year (95%
CI 2.01–2.25), which increased significantly to 3.47
cases/million/year (95% CI 3.22–3.73) from 2001 to 2004
(RR 1.39, 95% CI 1.31–1.47, p<0.001).
Clustered Cases
Epidemiologic and subtyping analysis identified 10
clusters of cases, which affected 60 patients and likely
reflected common-source outbreaks (15,16); these are
summarized in Table 1. When these cases were excluded,
a significant increase in disease in 2001–2004 compared
with 1990–2000 remained (RR 1.34, 95% CI 1.26–1.42,
p<0.001). Subsequent analysis is confined to 1,873 spo-
radic cases unless otherwise indicated.
Trends in Sporadic Cases
In 1990, sporadic nonpregnancy-associated listeriosis
accounted for 80% of the 114 cases reported, and in 2004
for 90% of the 205 cases reported (χ2 for trend p<0.001;
Figure 1). A total of 510 (44%) of 1,155 of the nonpreg-
nancy-associated patients and 29 (10%) of 287 of the spo-
radic pregnancy-associated patients died.
Data on patients’age were available for 1,543 (97%) of
the 1,586 nonpregnancy-associated cases. In 2001–2004,
the risk for nonpregnancy-associated listeriosis in persons
>60 years of age increased by almost half (RR 1.49, 95%
CI 1.39–1.60, p<0.001) compared with 1990–2000
(Figure 2). After 2000, the risk among 70- to 79-year-olds
(RR 1.32, 95% CI 1.20–1.45, p<0.001) and >80-year-olds
(1.51, 95% CI 1.33–1.71, p<0.001) was significantly high-
er than for 60- to 69-year-old patients. Sporadic patients
>60 years of age were more likely to die (405 [49%] of
828) than those <60 years of age (97 [31%] of 315,
χ2 p<0.001), and the likelihood of death increased with
increasing age in this group (χ2 for trend, p = 0.01).
Data on sex were available for 1,542 (99%) of the 1,543
nonpregnancy-associated patients for whom age was also
available. The increased risk in persons >60 years of age
during 2001–2004 compared with the risk in 1990–2000
was observed in both men (RR 1.47, 95% CI 1.34–1.62,
p<0.001) and women (RR 1.49, 95% CI 1.34–1.66,
p<0.001) and occurred in most regions of England and in
Wales (Figure 3).
Specimen collection dates were available for 1,088
(99%) of 1,102 nonpregnancy-associated patients >60
years of age; 503 (46%) cases occurred from July to
October. This pattern did not differ for nonpregnancy-asso-
ciated patients >60 years of age reported from 2001 to
2004 (206 [47%] of 442) compared with those reported
from 1990 to 2000 (297 [46%] of 646, χ2 p = 0.84).
Serotyping data were available for 889 (81%) of the
1,102 nonpregnancy-associated patients >60 years of age.
Serotypes 4b (436 [49%]) and 1/2 (430 [48%]) accounted
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change significantly during the study period (χ2 for trend,
p = 0.13). No significant differences were observed
between patients infected with serotypes 1/2 or 4b in terms
of age distribution or death. AFLP typing, applied to cul-
tures collected from 2002 to 2004 and used in conjunction
with serotyping, was available for 267 (99%) of 269 non-
pregnancy-associated patients >60 years of age. Fourteen,
18, and 16 different subtypes were reported in 2002, 2003,
and 2004 respectively; 2, 4, and 4 subtypes, respectively,
were unique to these years. Ten subtypes were responsible
for 241 (90%) of cases, and no individual type occurred
more frequently than 22% in any individual year or among
all cases.
Data on underlying illness were available for 830
(75%) of 1,102 nonpregnancy-associated patients >60
years of age; this proportion did not differ during
1990–2000 (90%) and 2001–2004 (89%). A single under-
lying condition was reported for 635 (77%) patients, >1
(12%) underlying condition was reported for 97 patients,
the specific underlying condition was not recorded for 10
patients (1%), and 88 patients had no underlying condition.
No significant change in the underlying conditions report-
ed for patients occurred in 1990–2000 compared with
2001–2004 (Table 2).
Among all nonpregnancy-associated patients, 380
(24%) had evidence of CNS infections, 1,114 (70%) had
bacteremia without CNS infections, 59 (4%) had other
conditions, and 33 (2%) could not be categorized. The pro-
portion of nonpregnancy-associated patients >60 years of
age with bacteremia alone increased significantly from
2001–2004 compared with 1990–2000 (85% vs. 76%,
χ2 p = 0.0004) (Figure 4). This difference in proportion
was not observed in nonpregnancy-associated patients <60
years of age (65% vs. 59%, χ2 p = 0.3). Among nonpreg-
nancy-associated patients >60 years of age with CNS
involvement, the proportion with an accompanying blood-
culture isolate from 2001 to 2004 (44 [73%] of 60) was not
significantly different than the rate from 1990 to 2000 (98
[65%] of 151, χ2 p = 0.24). Among all 264 pregnancy-
associated patients, the proportion with a blood-culture
isolate from 2001 to 2004 (40 [63%] of 64) was not signif-
icantly different from that in 1990–2000 (101 [51%] of
200, χ2 p = 0.09).
Patients’ names were available for 1,092 (99%) of
1,102 nonpregnancy-associated patients >60 years of age;
these were used as a marker for ethnicity. Most patients
(1,040, 95%) were classified as nonethnic on the basis of
their name. This proportion did not change from
1990–2000 (623 [96%] of 650) to 2001–2004 (417 [94%]
of 442, χ2 p = 0.44).
Human Listeriosis, England and Wales, 2001–2004
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Figure 1. Sporadic cases of listeriosis reported in England and
Wales, 1990–2004. Patients’ postal codes were available for 634 (58%) of
1,102 nonpregnancy-associated patients >60 years, and
indexes of deprivation were determined for 563 (89%).
The proportion of patients who fell into the quintiles of
deprivation 1–5 did not change during the surveillance
period (χ2 for trend p = 0.57, 0.69, 0.64, 0.05, and 0.14,
respectively).
Internet searches of the areas covered by the postal
codes of the 634 nonpregnancy-associated patients >60
years of age showed that, when genuine postal codes were
supplied (628, 99%), most (580, 92%) did not contain a
residential care home. This proportion did not differ from
2001–2004 (27 [9%] of 309) when compared with
1990–2000 (21 [7%] of 319, χ2 p = 0.31).
Discussion
Routine surveillance of human listeriosis in England
and Wales showed an upsurge in cases such that the annu-
al incidence is now comparable with other European coun-
tries with higher incidence (17). The clinical manifes-
tations have also changed: bacteremia in older patients
without CNS involvement predominates. Several con-
founding factors could explain the increase in cases and
changes in signs and symptoms.
Changes in reporting or referral could have accounted
for the observed increase in incidence. The surveillance of
listeriosis in England and Wales is passive, and such sys-
tems are prone to both underascertainment and pseudo-
outbreaks following increased interest in the public health
community. Although reporting artifacts cannot be exclud-
ed, we are unaware of increased interest in listeriosis from
2001 onwards. Furthermore, reporting and referrals did not
change enough to explain the increase.
Improvements in laboratory methods (especially in the
isolation of L. monocytogenes from blood) or changes in
local clinical practice (e.g., more detailed investigations of
patients with acute febrile illness seeking primary care)
might explain the increase in cases diagnosed or the altered
clinical manifestations. We are unaware of substantial
changes in blood culture techniques used in England and
Wales in the past decade that would increase the diagnosis
of listeriosis. Furthermore, although the introduction of
mandatory reporting of methicillin-resistant Staphylo-
coccus aureus bacteremia in England in 2001 has led to an
increase in blood cultures being taken, this is insufficient
to explain the increase or shift in clinical manifestations
described here (18,19). Further evidence that the increase
was not due to improved diagnostics is the absence of sta-
tistically significant increase in the isolation of L. monocy-
togenes from blood cultures from patients with CNS
infections or from pregnancy-associated patients.
Demographic changes in the population might have
resulted in an overrepresentation of patients from particular
age groups without a true increase in risk. Life expectancy
in the United Kingdom is increasing; therefore, an increase
in listeriosis in older patients is likely to occur. However,
calculations controlling for the changing age structure in
England and Wales during the surveillance period generates
a consistent increase in risk among those >60 years of age.
Medical advances have resulted in the UK population’s sur-
viving for longer with chronic conditions (20) with a likely
increased susceptibility to listeriosis. While the denomina-
tor data required to examine such changes in detail are
unavailable, changes would be unlikely to result in an
almost 3-fold increase in a single patient age group in a
short period without a concomitant increase in younger
patients with similar underlying conditions.
Changes in the pathogenicity of L. monocytogenes
might explain the change in disease manifestations.
However, the increase has been due to multiple subtypes,
which makes this unlikely. Furthermore, since the upsurge
was confined to a restricted patient age group, it is more
likely to reflect increased incidence through higher expo-
sure that accompanies behavioral changes.
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Figure 2. Risk for sporadic nonpregnancy-associated listeriosis by
age group, England and Wales, 1993–2004. Individual data shown
for years 2001–2004. 
Figure 3. Biannual risk for sporadic nonpregnancy-associated lis-
teriosis in patients >60 years of age, by region, England and
Wales, 1990–2004. E Mids, East Midlands; East, East of England;
N East, Northeast England; N West, Northwest England; S East,
Southeast England; S West, Southwest England; W Mids, West
Midlands, Wales; York & Hum, Yorkshire and the Humber. Having examined the most plausible sources of bias,
we believe that the observed upsurge and altered clinical
manifestations are genuine. Indeed, historical data suggest
that the current picture merely represents a continued shift
in the epidemiology and clinical manifestations of L.
monocytogenes infection in England and Wales (Table 3
(4,21).
The routine epidemiologic and microbiologic data col-
lected for cases of listeriosis in England and Wales are not
exhaustive; therefore, our retrospective examination of the
factors that have contributed to this upsurge is preliminary.
Nevertheless, we have demonstrated that the upsurge is
independent of sex; regional, seasonal, ethnic, or socioeco-
nomic differences; underlying conditions; or L. monocyto-
genes subtypes. Furthermore, most older patients in the
surveillance period did not reside in care homes and were
therefore unlikely to have changed exposure to institution-
al catering in such settings. UK food consumption/expen-
diture data also suggest that no major shift in the
consumption of major food groups by the older population
has occurred in recent years to explain the increase (22).
Investigations are continuing to establish the causes of
the increase and include application of discriminatory sub-
typing of L. monocytogenes isolates, coupled with the col-
lection of standardized clinical and epidemiologic data for
all patients. Hopefully, such steps will facilitate outbreak
detection and help identify their cause, as well as enable
investigations of factors specific to L. monocytogenes sub-
types among sporadic cases. However, analytical epidemi-
ology (including case-control studies) and molecular fin-
gerprinting of isolates have not always successfully identi-
fied the appropriate interventions to control outbreak-
associated and sporadic listeriosis, which suggests that
new approaches to investigation are required. Therefore, in
the absence of risk factors for listeriosis in this emerging
at-risk sector of the population, dietary advice on the
avoidance of high-risk foods should be provided routinely
to the elderly and immunocompromised and not just preg-
nant women.
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